Deceased Kidney Donor Transplant
Prof (Dr) Debabrata Mukherjee | Deceased Donor Transplant Specialist
Senior Director – Nephrology & Renal Transplant, Medanta Gurugram
Deceased Donor (Cadaveric) Renal Transplantation: An Essential Life-Line
For individuals battling End-Stage Renal Disease (ESRD) who do not possess a biologically compatible or legally viable living family donor, a Deceased Donor Kidney Transplant (also known as a Cadaveric Transplant) stands as the definitive surgical pathway to recovery. This complex clinical procedure involves transplanting a healthy, structurally sound kidney from an individual who has suffered irreversible brain-stem death but whose systemic organs are being maintained mechanically within an intensive care environment.
At Medanta – The Medicity, Gurugram, under the clinical management of Prof (Dr) Debabrata Mukherjee, cadaveric transplants are executed with absolute transparency, adhering strictly to institutional and state-level guidelines. Our specialized transplant squad handles every stage of the allocation timeline with severe chronological precision to protect organ viability.
National Regulatory Framework
Deceased organ allocation in India is systematically governed by federal protocols under the Transplantation of Human Organs Act (THOA). To be eligible to receive a cadaveric organ, all candidates must undergo legal and medical registration within the national registry via **NOTTO** (National Organ and Tissue Transplant Organization) or the respective state body (**SOTTO**), an infrastructure managed seamlessly at our Medanta Sector 38 hub.
The Deceased Donor Waitlist & Transplant Timeline
Because a deceased donor kidney can become available unexpectedly at any hour, the medical protocol is structured into three highly disciplined phases:
The recipient undergoes exhaustive immunological mapping, including **HLA (Human Leukocyte Antigen) Typing** and **PRA (Panel Reactive Antibody)** profiling. Extensive cardiovascular clearances, infectious disease screens, and malignancy exclusions are completed before changing the status to “Active” on the SOTTO/NOTTO register.
While awaiting allocation, patients must remain on optimal maintenance dialysis (hemodialysis or peritoneal) and undergo regular medical reviews. When a brain-dead donor matches your blood pool, a high-priority alert call is made, requiring the patient to arrive at Medanta immediately while fasting.
As the organ is transferred to our facility, a mandatory final **CDC (Complement-Dependent Cytotoxicity) Crossmatch** is run using fresh recipient serum. If the match is negative, the patient enters the operating suite where the harvested kidney is skillfully plumbed to the iliac blood vessels.
Critical Clinical Factors Governing Cadaveric Success
Unlike living donor surgeries where everything is electively planned, deceased donor outcomes are influenced by unique clinical variables that require specialized nephrological judgment:
- Cold Ischemia Time (CIT): This measures the hours the kidney spends outside a human body on preservation ice. Dr. Mukherjee’s operational protocols prioritize keeping CIT ideally under 12–18 hours to minimize the risk of Delayed Graft Function (DGF).
- Delayed Graft Function (DGF) Management: Deceased donor kidneys sometimes experience a temporary “stunned” state upon reperfusion, requiring a few post-op dialysis sessions before starting to produce urine normally. This is a known, manageable phenomenon that does not hurt long-term graft survival.
- Donor Medical Scoring: Organs are thoroughly screened using standardized systems (such as the Kidney Donor Profile Index) to assess historical parameters like donor age, blood pressure trends, and baseline renal clearings.
- Induction Immunosuppression: Because cadaveric organs carry higher baseline immunogenicity than living tissue, advanced biological agents (like anti-thymocyte globulin or basiliximab) are expertly administered at induction to shut down early cellular rejection lines.
Comprehensive Follow-Up Infrastructure
Successfully exiting the operating theater marks the beginning of a lifelong commitment to preserving the new organ. Deceased donor recipients require highly specialized ambulatory care during the first 12 weeks post-surgery.
Our critical care nephrology program tracks calcineurin inhibitor drug targets, monitors for opportunistic infections (like BK virus or CMV), and titrates anti-rejection regimens to keep your calculated glomerular filtration rate (eGFR) running at healthy, stable levels.
Prof (Dr) D Mukherjee is an alumnus of the prestigious Armed Forces Medical College, Pune where he did his MBBS & MD (Medicine). Subsequently he went on to do his DM (Nephrology) from PGIMER Chandigarh, which is the foremost training institution for nephrology in India.